& Kavanaugh, M
Understanding what to expect helps you navigate treatment safely and effectively
Qualifying for GLP-1 therapy when following keto Qualifying for GLP-1 prescriptions typically requires a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
When you take GLP-1 weight loss medication, it: Slows gastric emptying : Food stays in your stomach longer, helping you feel full and satisfied Reduces appetite : Many people experience significantly decreased food cravings Improves insulin sensitivity : Your body becomes more efficient at processing sugar Stabilizes blood sugar : This helps prevent the energy crashes that can trigger overeating Beyond weight loss, many people report improved energy levels, better sleep, and reduced obsession with food
Usage is confined to in vitro testing and laboratory experimentation exclusively
Peptides that aid insulin sensitivity and glucose control include tirzepatide-esque GLP-1/GIP agonists in theory, as well as research peptides like AOD9604 and CJC-1295 when combined with DAC-free protocols